Roberto Marchioli

Active 1991–2026

57
Papers
19,860
Citations
55
h-index
57
i10-index

Citations

Citations per year for Roberto Marchioli1964: 1 citations1983: 1 citations1985: 1 citations1991: 1 citations1994: 1 citations1996: 2 citations1997: 1 citations1998: 2 citations1999: 10 citations2000: 31 citations2001: 51 citations2002: 54 citations2003: 107 citations2004: 117 citations2005: 148 citations2006: 151 citations2007: 189 citations2008: 214 citations2009: 180 citations2010: 161 citations2011: 196 citations2012: 211 citations2013: 220 citations2014: 168 citations2015: 172 citations2016: 190 citations2017: 152 citations2018: 188 citations2019: 535 citations2020: 514 citations2021: 392 citations2022: 319 citations2023: 241 citations2024: 417 citations2025: 137 citations2026: 20 citations1965–1982: no citations, so these years are not shown1984: no citations, so this year is not shown1986–1990: no citations, so these years are not shown1992–1993: no citations, so these years are not shown1995: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,845 citing papers, 23.1% of this breakdownUnited Kingdom: 807 citing papers, 10.1% of this breakdownItaly: 654 citing papers, 8.2% of this breakdownGermany: 393 citing papers, 4.9% of this breakdownChina: 336 citing papers, 4.2% of this breakdownCanada: 334 citing papers, 4.2% of this breakdownNetherlands: 312 citing papers, 3.9% of this breakdownFrance: 308 citing papers, 3.8% of this breakdownAustralia: 275 citing papers, 3.4% of this breakdownSpain: 264 citing papers, 3.3% of this breakdownSweden: 186 citing papers, 2.3% of this breakdownJapan: 152 citing papers, 1.9% of this breakdown
0%23.1%Other 26.7%

Fields

  • Medicine69.6%
  • Nursing15.5%
  • Biochemistry, Genetics and Molecular Biology8.7%
  • Immunology and Microbiology1.4%
  • Environmental Science0.7%
  • Neuroscience0.7%
  • Other3.4%

Topics

  • Lipoproteins and Cardiovascular Health6.9%
  • Fatty Acid Research and Health6.1%
  • Myeloproliferative Neoplasms: Diagnosis and Treatment4.2%
  • Diabetes, Cardiovascular Risks, and Lipoproteins4%
  • Eicosanoids and Hypertension Pharmacology2.4%
  • Nutritional Studies and Diet2.4%
  • Other74%

Coauthors

All papers

Open in search
  1. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kyoichi Mizuno, Kausik K. Ray, Ian Ford - The Lancet 2010 cited by 2,447

  2. Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Heather Halls, Charlie Harper, C. Hawkins, William G. Herrington, G. A. Hitman, Hallvard Holdaas, Lisa Holland, Alan G. Jardine, J. Wouter Jukema, John J.P. Kastelein, Sharon Kean, Anthony Keech, Adrienne Kirby, John Kjekshus, Genell L. Knatterud, Robert H. Knopp, Wolfgang Köenig, Michael J. Koren, Vera Krane, Martin Landray, John C. LaRosa, Eva Lonn, Peter W. Macfarlane, Stephen MacMahon, Aldo P. Maggioni, Roberto Marchioli, Ian C. Marschner, Borislava Mihaylova, Lemuel A. Moyé, Sabina A. Murphy, Haruo Nakamura, Andrew Neil, Connie B. Newman, Rachel O’Connell, Chris J. Packard, Sarah Parish, Terje Pedersen, Richard Peto, Marc A. Pfeffer, Neil Poulter, David Preiss, Christina Reith, Paul M. Ridker, Michele Robertson, Frank M. Sacks, Naveed Sattar, Roland E. Schmieder, Patrick W. Serruys, Peter Sever, John Shaw, Charles L. Shear, John Simes, Peter Sleight, Enti Spata, Luigi Tavazzi, Jonathan A. Tobert, Gianni Tognoni, Andrew Tonkin, Stella Trompet, George Varigos, Christoph Wanner, Hans Wedel, Harvey D. White, John Wikstrand, Lars Wilhelmsen, Kate Wilson, Robin Young, Salim Yusuf, Faı̈ez Zannad - The Lancet 2019 cited by 791

  3. Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael Clearfield, Stuart M. Cobbe, Helen M. Colhoun, Björn Dahlöf, Barry R. Davis, James A. de Lemos, John R. Downs, Paul N. Durrington, Bengt Fellström, Ian Ford, Maria Grazia Franzosi, John A. Fuller, Curt D. Furberg, Robert J. Glynn, David Gordon, Antonio M. Gotto, Richard H. Grimm, Ajay Gupta, C. Hawkins, G. A. Hitman, Hallvard Holdaas, Alan G. Jardine, J. Wouter Jukema, John J.P. Kastelein, Sharon Kean, John Kjekshus, Genell L. Knatterud, Robert H. Knopp, Wolfgang Köenig, Michael J. Koren, Vera Krane, Martin Landray, John C. LaRosa, Roberto Latini, Eva Lonn, Donata Lucci, Jean MacFadyen, Peter W. Macfarlane, Stephen MacMahon, Aldo P. Maggioni, Roberto Marchioli, Ian C. Marschner, Lemuel A. Moyé, Sabina A. Murphy, Andrew Neil, Enrico Nicolis, Chris J. Packard, Sarah Parish, Terje R. Pedersen, Richard Peto, Marc A. Pfeffer, Neil R Poulter, Sara Pressel, Jeffrey L. Probstfield, Mahboob Rahman, Paul M. Ridker, Michele Robertson, Frank M. Sacks, Naveed Sattar, Roland E. Schmieder, Patrick W. Serruys, Peter Sever, John Shaw, James Shepherd, Lara M. Simpson, Peter Sleight, Luigi Tavazzi, Gianni Tognoni, Andrew Tonkin, Stella Trompet and 28 more - The Lancet 2022 cited by 246

  4. Cardiovascular Events and Intensity of Treatment in Polycythemia Vera

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alessandro Maria Vannucchi, Tiziano Barbui - New England Journal of Medicine 2012 cited by 820

  5. Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stella Trompet, Harvey D. White, Salim Yusuf, Jane Armitage, Anthony Keech, John Simes, Rory Collins, Colin Baigent, Elizabeth H Barnes, Jordan Fulcher, William G. Herrington, Adrienne Kirby, Rachel O’Connell, Pierre Amarenco, Hiroyuki Arashi, Philip J. Barter, D. J. Betteridge, Michael A. Blazing, Gerard J Blauw, Jackie Bosch, Louise Bowman, Eugene Braunwald, Richard Bulbulia, Robert Byington, Michael Clearfield, Stuart M. Cobbe, Björn Dahlöf, Barry R. Davis, James A. de Lemos, John R. Downs, Bengt Fellström, Marcus Flather, Ian Ford, Maria Grazia Franzosi, John A. Fuller, Curt D. Furberg, Robert J. Glynn, Uri Goldbourt, David Gordon, Antonio M. Gotto, Richard Grimm, A Gupta, C. Hawkins, Richard Haynes, Hallvard Holdaas, Jemma C. Hopewell, Alan G. Jardine, John J.P. Kastelein, Sharon Kean, Patricia M. Kearney, George D. Kitas, John Kjekshus, Genell L. Knatterud, Robert H. Knopp, Michael J. Koren, Vera Krane, Martin Landray, John C. LaRosa, Roberto Latini, Eva Lonn, Donata Lucci, Jean MacFadyen, Peter W. Macfarlane, Stephen MacMahon, Aldo P. Maggioni, Roberto Marchioli, Lemuel A. Moyé, Sabina A. Murphy, Andrew Neil, Enrico Nicolis and 32 more - The Lancet Diabetes & Endocrinology 2024 cited by 137

  6. HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nita G. Forouhi, N. Charlotte Onland‐Moret, Yvonne T. van der Schouw, Renate B. Schnabel, Jaroslav A. Hubáček, Růžena Kubínová, Miglė Bacevičienė, Abdonas Tamošiūnas, Andrzej Pająk, Romanvan Topor-Madry, Urszula Stepaniak, Sofia Malyutina, Damiano Baldassarre, Bengt Sennblad, Elena Tremoli, Ulf dé Fairé, Fabrizio Veglia, Ian Ford, J. Wouter Jukema, Rudi G. J. Westendorp, Gert J. de Borst, Pim A. de Jong, Ale Algra, Wilko Spiering, Anke H. Maitland‐van der Zee, Olaf H. Klungel, Anthonius de Boer, Pieter A. Doevendans, Charles B. Eaton, Jennifer G. Robinson, David Duggan, John Kjekshus, John R. Downs, Antonio M. Gotto, Anthony Keech, Roberto Marchioli, Gianni Tognoni, Peter S. Sever, Neil R Poulter, David D. Waters, Terje R. Pedersen, Pierre Amarenco, Haruo Nakamura, John J.V. McMurray, James Lewsey, Daniel I. Chasman, Paul M. Ridker, Aldo P. Maggioni, Luigi Tavazzi, Kausik K. Ray, Sreenivasa Rao Kondapally Seshasai, JoAnn E. Manson, Jackie F. Price, Peter H. Whincup, Richard Morris, Debbie A. Lawlor, George Davey Smith, Yoav Ben‐Shlomo, Pamela J. Schreiner, Myriam Fornage, David S. Siscovick, Mary Cushman, Meena Kumari, Nick J Wareham, W. M. Monique Verschuren, Susan Redline, Sanjay R. Patel, John C. Whittaker, Anders Hamsten, Joseph A. Delaney and 33 more - The Lancet 2014 cited by 710

  7. Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks

    Authors: , , , , , , , , , , , , , , , - JAMA Cardiology 2018 cited by 639

  8. A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Joseph Tripodi, Noushin Farnoud, Alexander V. Penson, Rona Singer Weinberg, Leah Price, Judith D. Goldberg, Tiziano Barbui, Roberto Marchioli, Gianni Tognoni, Raajit K. Rampal, Ruben A. Mesa, Amylou C. Dueck, Ronald Hoffman - Blood 2022 cited by 129

  9. Vascular and Neoplastic Risk in a Large Cohort of Patients With Polycythemia Vera

    Authors: , , , , , , , , , - Journal of Clinical Oncology 2005 cited by 719

  10. Efficacy and Safety of Low-Dose Aspirin in Polycythemia Vera

    Authors: , , , , , , - New England Journal of Medicine 2004 cited by 1,000

  11. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico.

    Authors: , , - 1999 cited by 2,065

  12. Early Protection Against Sudden Death by n-3 Polyunsaturated Fatty Acids After Myocardial Infarction

    Authors: , , , , , , , , , , , , , , , , , , , , - Circulation 2002 cited by 1,315

  13. Plasma Fibrinogen Level and the Risk of Major Cardiovascular Diseases and Nonvascular Mortality

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , J Pekkanen, Juha Pekkanen, Ralph B. D’Agostino, William B. Kannel, Peter W.F. Wilson, G. Tofler, Carmen Luisa Arocha-Piñango, Álvaro Rodríguez-Larralde, Eva Nagy, Michael R. Mijares, Raúl E. Espinosa, E Rodriquez-Roa, Elena Ryder, María Diez‐Ewald, G Campos, E Torres, Esther Torres, Roberto Marchioli, Franco Valagussa, Annika Rosengren, Lars Wilhelmsen, George Lappas, Henry Eriksson, Peter Cremer, D. Nagel, J. David Curb, Bryan S. Quintanilla Rodriguez, Katsuhiko Yano, Jukka T. Salonen, K. Nyyssönen, T-P Tuomainen, B Hedblad, Peter Lind, Hannelore Loewel, W Koenig, T W Meade, J Cooper, Bianca De Stavola, Christine Knottenbelt, George J. Miller, J Cooper, Kenneth A. Bauer, R D Rosenberg, Shinichi Sato, Akihiko Kitamura, Yoshihiko Naito, Timo Palosuo, Pierre Ducimetière, Philippe Amouyel, D Arveiler, A. E. Evans, Jean Ferrières, I. Juhan‐Vague, Anne Bingham, H Schulte, G. Aßmann, Bernard Cantin, Benoı̂t Lamarche, JP Després, Gilles R. Dagenais, H Tunstall-Pedoe, Mark Woodward, Yoav Ben‐Shlomo, George Davey Smith, Vittorio Palmieri, Jwu‐Lai Yeh, Alicja R. Rudnicka, Paul M. Ridker, Francesco Rodeghiero, Alberto Tosetto and 17 more - JAMA 2005 cited by 1,113

  14. Leukocytosis as a major thrombotic risk factor in patients with polycythemia vera

    Authors: , , , , , , , - Blood 2006 cited by 413

  15. A randomized clinical trial of high‐intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS)

    Authors: , , , , , , , , , , , - Journal of Thrombosis and Haemostasis 2005 cited by 587

  16. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Haematologica 2008 cited by 359

  17. The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John R. Downs, John J.V. McMurray - European Heart Journal 2015 cited by 158

  18. Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia

    Authors: , , , , , , , , , , , , , , , , , , , , , - Blood 2007 cited by 444

  19. Prevalence and Prognostic Value of Elevated Urinary Albumin Excretion in Patients With Chronic Heart Failure

    Authors: , , , , , , , , , , , , - Circulation Heart Failure 2009 cited by 127

  20. Inflammation and thrombosis in essential thrombocythemia and polycythemia vera: different role of C-reactive protein and pentraxin 3

    Authors: , , , , , , , , , , , , , , , , - Haematologica 2010 cited by 191

  21. Effects of n -3 Polyunsaturated Fatty Acids and of Rosuvastatin on Left Ventricular Function in Chronic Heart Failure: A Substudy of GISSI-HF trial

    Authors: , , , , , , , , , , , , - European Journal of Heart Failure 2010 cited by 82

  22. Fish Oil and Postoperative Atrial Fibrillation

    Authors: , , , , , , , , , , , , , - JAMA 2012 cited by 231

  23. Incidence of new-onset diabetes and impaired fasting glucose in patients with recent myocardial infarction and the effect of clinical and lifestyle risk factors

    Authors: , , , , , , , - The Lancet 2007 cited by 184

  24. Predictors of Mortality in 6975 Patients With Chronic Heart Failure in the Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico-Heart Failure Trial

    Authors: , , , , , , , , , , - Circulation Heart Failure 2012 cited by 133